窥得儿医药（QDEL）今日盘中股价大幅下挫21.67%，引发了市场的广泛关注。
消息面上，根据华尔街分析师发布的研究报告，摩根大通将窥得儿医药的目标价从25美元大幅下调至15美元，降幅高达40%。分析师下调目标价通常反映了对公司未来业绩或前景的担忧，这可能是导致投资者在盘中交易时段抛售股票、股价急剧下跌的主要原因。
窥得儿医药（QDEL）今日盘中股价大幅下挫21.67%，引发了市场的广泛关注。
消息面上，根据华尔街分析师发布的研究报告，摩根大通将窥得儿医药的目标价从25美元大幅下调至15美元，降幅高达40%。分析师下调目标价通常反映了对公司未来业绩或前景的担忧，这可能是导致投资者在盘中交易时段抛售股票、股价急剧下跌的主要原因。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.